+499.5%
MRNA vs VCIT
+1.3%
+498.2%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | VCIT | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | 0.0% | -2.2% | -2.1% |
| 7D | +5.5% | -0.3% | +5.8% | +8.9% |
| 30D | +158.7% | -0.8% | +159.5% | +185.6% |
| 3M | +182.1% | -1.0% | +183.1% | +217.8% |
| 6M | +151.8% | -1.8% | +153.7% | +204.9% |
| YTD | +393.6% | -0.7% | +394.3% | +455.1% |
| 1Y | +499.5% | +1.0% | +498.5% | +502.6% |
| All | +499.5% | +1.3% | +498.2% | +502.6% |
Cumulative growth
Daily Returns
Daily percentage return beside VCIT.
Daily Out/Under-Performance
Portfolio return minus VCIT return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VCIT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded VCIT wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling